ID   SYT_ECOLI               Reviewed;         642 AA.
AC   P0A8M3; P00955; P78166; P78241;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   07-JUN-2005, sequence version 1.
DT   07-APR-2021, entry version 146.
DE   RecName: Full=Threonine--tRNA ligase {ECO:0000255|HAMAP-Rule:MF_00184};
DE            EC=6.1.1.3 {ECO:0000255|HAMAP-Rule:MF_00184, ECO:0000269|PubMed:10319817};
DE   AltName: Full=Threonyl-tRNA synthetase {ECO:0000255|HAMAP-Rule:MF_00184};
DE            Short=ThrRS {ECO:0000255|HAMAP-Rule:MF_00184};
GN   Name=thrS {ECO:0000255|HAMAP-Rule:MF_00184};
GN   OrderedLocusNames=b1719, JW1709;
OS   Escherichia coli (strain K12).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83333;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=6353409; DOI=10.1073/pnas.80.20.6152;
RA   Mayaux J.-F., Fayat G., Fromant M., Springer M., Grunberg-Manago M.,
RA   Blanquet S.;
RT   "Structural and transcriptional evidence for related thrS and infC
RT   expression.";
RL   Proc. Natl. Acad. Sci. U.S.A. 80:6152-6156(1983).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=9097039; DOI=10.1093/dnares/3.6.363;
RA   Aiba H., Baba T., Fujita K., Hayashi K., Inada T., Isono K., Itoh T.,
RA   Kasai H., Kashimoto K., Kimura S., Kitakawa M., Kitagawa M., Makino K.,
RA   Miki T., Mizobuchi K., Mori H., Mori T., Motomura K., Nakade S.,
RA   Nakamura Y., Nashimoto H., Nishio Y., Oshima T., Saito N., Sampei G.,
RA   Seki Y., Sivasundaram S., Tagami H., Takeda J., Takemoto K., Takeuchi Y.,
RA   Wada C., Yamamoto Y., Horiuchi T.;
RT   "A 570-kb DNA sequence of the Escherichia coli K-12 genome corresponding to
RT   the 28.0-40.1 min region on the linkage map.";
RL   DNA Res. 3:363-377(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=9278503; DOI=10.1126/science.277.5331.1453;
RA   Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V.,
RA   Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F.,
RA   Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J., Mau B.,
RA   Shao Y.;
RT   "The complete genome sequence of Escherichia coli K-12.";
RL   Science 277:1453-1462(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=16738553; DOI=10.1038/msb4100049;
RA   Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S.,
RA   Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.;
RT   "Highly accurate genome sequences of Escherichia coli K-12 strains MG1655
RT   and W3110.";
RL   Mol. Syst. Biol. 2:E1-E5(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-47, AND MECHANISM OF TRANSLATION
RP   REGULATION.
RX   PubMed=3086882; DOI=10.1073/pnas.83.12.4384;
RA   Springer M., Graffe M., Butler J.S., Grunberg-Manago M.;
RT   "Genetic definition of the translational operator of the threonine-tRNA
RT   ligase gene in Escherichia coli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 83:4384-4388(1986).
RN   [6]
RP   MECHANISM OF TRANSLATION REGULATION, AND RNA-BINDING.
RX   PubMed=2254931; DOI=10.1016/s0022-2836(05)80321-3;
RA   Moine H., Romby P., Springer M., Grunberg-Manago M., Ebel J.P.,
RA   Ehresmann B., Ehresmann C.;
RT   "Escherichia coli threonyl-tRNA synthetase and tRNA(Thr) modulate the
RT   binding of the ribosome to the translational initiation site of the thrS
RT   mRNA.";
RL   J. Mol. Biol. 216:299-310(1990).
RN   [7]
RP   IDENTIFICATION BY 2D-GEL.
RX   PubMed=9298644; DOI=10.1002/elps.1150180805;
RA   VanBogelen R.A., Abshire K.Z., Moldover B., Olson E.R., Neidhardt F.C.;
RT   "Escherichia coli proteome analysis using the gene-protein database.";
RL   Electrophoresis 18:1243-1251(1997).
RN   [8]
RP   FUNCTION IN AMINOACYLATION AND EDITING, AND DOMAIN.
RX   PubMed=15079065; DOI=10.1073/pnas.0401530101;
RA   Beebe K., Merriman E., Ribas De Pouplana L., Schimmel P.;
RT   "A domain for editing by an archaebacterial tRNA synthetase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:5958-5963(2004).
RN   [9]
RP   FUNCTION, ACTIVITY REGULATION, BIOPHYSICOCHEMICAL PROPERTIES, DISRUPTION
RP   PHENOTYPE, ANTIBIOTIC RESISTANCE, AND MUTAGENESIS OF PRO-296; THR-307;
RP   HIS-309; HIS-337 AND LEU-489.
RX   PubMed=15507440; DOI=10.1074/jbc.m411039200;
RA   Ruan B., Bovee M.L., Sacher M., Stathopoulos C., Poralla K.,
RA   Francklyn C.S., Soell D.;
RT   "A unique hydrophobic cluster near the active site contributes to
RT   differences in borrelidin inhibition among threonyl-tRNA synthetases.";
RL   J. Biol. Chem. 280:571-577(2005).
RN   [10]
RP   FUNCTION, REACTION MECHANISM, BIOPHYSICOCHEMICAL PROPERTIES, AND
RP   MUTAGENESIS OF HIS-309; ARG-363; GLN-381; LYS-465 AND GLN-479.
RX   PubMed=18997014; DOI=10.1073/pnas.0804247105;
RA   Minajigi A., Francklyn C.S.;
RT   "RNA-assisted catalysis in a protein enzyme: The 2'-hydroxyl of tRNA(Thr)
RT   A76 promotes aminoacylation by threonyl-tRNA synthetase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:17748-17753(2008).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-286, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   STRAIN=K12 / JW1106, and K12 / MG1655 / ATCC 47076;
RX   PubMed=18723842; DOI=10.1074/mcp.m800187-mcp200;
RA   Zhang J., Sprung R., Pei J., Tan X., Kim S., Zhu H., Liu C.F.,
RA   Grishin N.V., Zhao Y.;
RT   "Lysine acetylation is a highly abundant and evolutionarily conserved
RT   modification in Escherichia coli.";
RL   Mol. Cell. Proteomics 8:215-225(2009).
RN   [12] {ECO:0007744|PDB:1QF6}
RP   X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) IN COMPLEX WITH COGNATE TRNA; AMP AND
RP   ZINC, FUNCTION, SUBUNIT, DOMAIN, AND MUTAGENESIS OF CYS-334; HIS-385 AND
RP   HIS-511.
RX   PubMed=10319817; DOI=10.1016/s0092-8674(00)80746-1;
RA   Sankaranarayanan R., Dock-Bregeon A.-C., Romby P., Caillet J., Springer M.,
RA   Rees B., Ehresmann C., Ehresmann B., Moras D.;
RT   "The structure of threonyl-tRNA synthetase-tRNA(Thr) complex enlightens its
RT   repressor activity and reveals an essential zinc ion in the active site.";
RL   Cell 97:371-381(1999).
RN   [13] {ECO:0007744|PDB:1FYF}
RP   X-RAY CRYSTALLOGRAPHY (1.65 ANGSTROMS) OF 242-642 IN COMPLEX WITH EDITING
RP   SUBSTRATE ANALOG AND ZINC, FUNCTION, SUBUNIT, AND MUTAGENESIS OF
RP   73-HIS--HIS-77 AND ASP-180.
RX   PubMed=11136973; DOI=10.1016/s0092-8674(00)00191-4;
RA   Dock-Bregeon A., Sankaranarayanan R., Romby P., Caillet J., Springer M.,
RA   Rees B., Francklyn C.S., Ehresmann C., Moras D.;
RT   "Transfer RNA-mediated editing in threonyl-tRNA synthetase. The class II
RT   solution to the double discrimination problem.";
RL   Cell 103:877-884(2000).
RN   [14] {ECO:0007744|PDB:1EVK, ECO:0007744|PDB:1EVL}
RP   X-RAY CRYSTALLOGRAPHY (1.55 ANGSTROMS) OF 242-642 IN COMPLEX WITH THREONINE
RP   AND ITS ANALOG AND ZINC, FUNCTION, CATALYTIC ACTIVITY, AND SUBUNIT.
RX   PubMed=10881191; DOI=10.1038/75856;
RA   Sankaranarayanan R., Dock-Bregeon A.-C., Rees B., Bovee M., Caillet J.,
RA   Romby P., Francklyn C.S., Moras D.;
RT   "Zinc ion mediated amino acid discrimination by threonyl-tRNA synthetase.";
RL   Nat. Struct. Biol. 7:461-465(2000).
RN   [15] {ECO:0007744|PDB:1KOG}
RP   X-RAY CRYSTALLOGRAPHY (3.50 ANGSTROMS) OF 242-642 IN COMPLEX WITH OPERATOR
RP   FRAGMENT OF MRNA AND ZINC, FUNCTION, AND SUBUNIT.
RX   PubMed=11953757; DOI=10.1038/nsb789;
RA   Torres-Larios A., Dock-Bregeon A.C., Romby P., Rees B.,
RA   Sankaranarayanan R., Caillet J., Springer M., Ehresmann C., Ehresmann B.,
RA   Moras D.;
RT   "Structural basis of translational control by Escherichia coli threonyl
RT   tRNA synthetase.";
RL   Nat. Struct. Biol. 9:343-347(2002).
RN   [16] {ECO:0007744|PDB:1TJE, ECO:0007744|PDB:1TKE, ECO:0007744|PDB:1TKG, ECO:0007744|PDB:1TKY}
RP   X-RAY CRYSTALLOGRAPHY (1.46 ANGSTROMS) OF 1-224 (EDITING DOMAIN) IN COMPLEX
RP   WITH EDITING ANALOGS, FUNCTION, POSSIBLE EDITING REACTION MECHANISM,
RP   DOMAIN, AND MUTAGENESIS OF LYS-156; CYS-182 AND HIS-186.
RX   PubMed=15525511; DOI=10.1016/j.molcel.2004.10.002;
RA   Dock-Bregeon A.C., Rees B., Torres-Larios A., Bey G., Caillet J., Moras D.;
RT   "Achieving error-free translation; the mechanism of proofreading of
RT   threonyl-tRNA synthetase at atomic resolution.";
RL   Mol. Cell 16:375-386(2004).
RN   [17] {ECO:0007744|PDB:4HWO, ECO:0007744|PDB:4HWP, ECO:0007744|PDB:4HWR, ECO:0007744|PDB:4HWS}
RP   X-RAY CRYSTALLOGRAPHY (1.70 ANGSTROMS) OF 242-642 IN COMPLEX WITH
RP   INHIBITORS AND ZINC, SUBUNIT, AND BIOTECHNOLOGY.
RX   PubMed=23362938; DOI=10.1021/jm301756m;
RA   Teng M., Hilgers M.T., Cunningham M.L., Borchardt A., Locke J.B.,
RA   Abraham S., Haley G., Kwan B.P., Hall C., Hough G.W., Shaw K.J., Finn J.;
RT   "Identification of bacteria-selective threonyl-tRNA synthetase substrate
RT   inhibitors by structure-based design.";
RL   J. Med. Chem. 56:1748-1760(2013).
RN   [18] {ECO:0007744|PDB:4P3O, ECO:0007744|PDB:4P3P}
RP   X-RAY CRYSTALLOGRAPHY (2.10 ANGSTROMS) OF 242-642 IN COMPLEX WITH
RP   BORRELIDIN AND ZINC, ACTIVITY REGULATION, AND SUBUNIT.
RX   PubMed=25824639; DOI=10.1038/ncomms7402;
RA   Fang P., Yu X., Jeong S.J., Mirando A., Chen K., Chen X., Kim S.,
RA   Francklyn C.S., Guo M.;
RT   "Structural basis for full-spectrum inhibition of translational functions
RT   on a tRNA synthetase.";
RL   Nat. Commun. 6:6402-6402(2015).
CC   -!- FUNCTION: Catalyzes the attachment of threonine to tRNA(Thr) in a two-
CC       step reaction: L-threonine is first activated by ATP to form Thr-AMP
CC       and then transferred to the acceptor end of tRNA(Thr) (PubMed:15079065,
CC       PubMed:10881191, PubMed:18997014). The rate-limiting step is amino acid
CC       activation in the presence of tRNA (PubMed:18997014). The 2'-OH of the
CC       acceptor base (adenine 76, A76) of tRNA(Thr) and His-309 collaborate to
CC       transfer L-Thr to the tRNA; substitution of 2'-OH of A76 with hydrogen
CC       or fluorine decreases transfer efficiency 760 and 100-fold respectively
CC       (PubMed:18997014). The zinc ion in the active site discriminates
CC       against charging of the isosteric amino acid valine (PubMed:10881191).
CC       Also activates L-serine, but does not detectably transfer it to
CC       tRNA(Thr) (PubMed:15079065). Edits incorrectly charged L-seryl-
CC       tRNA(Thr) via its editing domain (PubMed:15079065, PubMed:11136973,
CC       PubMed:15525511), in a post-transfer reaction probably via water-
CC       mediated hydrolysis (PubMed:15525511). {ECO:0000269|PubMed:10319817,
CC       ECO:0000269|PubMed:10881191, ECO:0000269|PubMed:11136973,
CC       ECO:0000269|PubMed:15079065, ECO:0000269|PubMed:15525511,
CC       ECO:0000269|PubMed:18997014}.
CC   -!- FUNCTION: ThrS is also a translational repressor protein, it controls
CC       binds its own mRNA in the operator region upstream of the start codon
CC       (PubMed:3086882). The mRNA region upstream of the start codon has a
CC       tRNA-like secondary structure; mRNA and tRNA compete for binding to
CC       ThrRS (PubMed:2254931). ThrRS represses translation by preventing the
CC       ribosome from to mRNA, and tRNA(Thr) acts as an antirepressor allowing
CC       fine level control of enzyme synthesis (PubMed:2254931). X-ray
CC       structures prove that operator mRNA and tRNA bind to overlapping sites
CC       in the protein (PubMed:10319817, PubMed:11953757).
CC       {ECO:0000269|PubMed:10319817, ECO:0000269|PubMed:11953757,
CC       ECO:0000269|PubMed:2254931, ECO:0000269|PubMed:3086882}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonine + tRNA(Thr) = AMP + diphosphate + H(+) + L-
CC         threonyl-tRNA(Thr); Xref=Rhea:RHEA:24624, Rhea:RHEA-COMP:9670,
CC         Rhea:RHEA-COMP:9704, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:33019, ChEBI:CHEBI:57926, ChEBI:CHEBI:78442,
CC         ChEBI:CHEBI:78534, ChEBI:CHEBI:456215; EC=6.1.1.3;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_00184,
CC         ECO:0000269|PubMed:10319817, ECO:0000269|PubMed:10881191,
CC         ECO:0000269|PubMed:18997014};
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_00184};
CC       Note=Binds 1 zinc ion per subunit. It helps recognize and select the
CC       amino acid substrate, and thus has neither a purely catalytic or
CC       structural role (PubMed:10881191). {ECO:0000269|PubMed:10319817,
CC       ECO:0000269|PubMed:10881191, ECO:0000269|PubMed:11136973,
CC       ECO:0000269|PubMed:11953757, ECO:0000269|PubMed:23362938,
CC       ECO:0000269|PubMed:25824639};
CC   -!- ACTIVITY REGULATION: Inhibited non-competitively by borrelidin (BN, KI
CC       is 3.7 nM) which binds in a 1:1 stoichiometry, inhibiting L-thr
CC       activation (PubMed:15507440). BN binds to 4 distinct subsites in the
CC       protein, preventing binding of all 3 substrates; BN also inhibits human
CC       ThrRS, and thus it is not useful as an antibiotic (PubMed:25824639).
CC       {ECO:0000269|PubMed:15507440, ECO:0000269|PubMed:25824639}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=94 uM for ATP {ECO:0000269|PubMed:15507440};
CC         KM=110 uM for L-threonine activation {ECO:0000269|PubMed:10881191,
CC         ECO:0000269|PubMed:15507440};
CC         KM=120 uM for L-threonine activation {ECO:0000269|PubMed:18997014};
CC         KM=0.86 uM for L-threonine aminoacylation
CC         {ECO:0000269|PubMed:18997014};
CC         KM=1.95 mM for beta-hydroxynorvaline activation
CC         {ECO:0000269|PubMed:10881191};
CC         KM=81.5 mM for L-serine activation {ECO:0000269|PubMed:10881191};
CC         Note=kcat is 36, 22 and 26 s(-1) for L-threonine, beta-
CC         hydroxynorvaline and L-serine respectively.
CC         {ECO:0000269|PubMed:10881191};
CC   -!- SUBUNIT: Homodimer (PubMed:10319817, PubMed:11136973, PubMed:10881191,
CC       PubMed:11953757, PubMed:23362938, PubMed:25824639); binds 2 tRNA(Thr)
CC       per homodimer, each tRNA contacts both monomers and makes specific
CC       contacts with the anticodon and acceptor stems (PubMed:10319817).
CC       {ECO:0000269|PubMed:10319817, ECO:0000269|PubMed:10881191,
CC       ECO:0000269|PubMed:11136973, ECO:0000269|PubMed:11953757,
CC       ECO:0000269|PubMed:23362938, ECO:0000269|PubMed:25824639}.
CC   -!- INTERACTION:
CC       P0A8M3; P0A7L0: rplA; NbExp=3; IntAct=EBI-551254, EBI-543771;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_00184}.
CC   -!- DOMAIN: The protein structure shows 2 N-terminal domains, the central
CC       catalytic and C-terminal domain (PubMed:10319817). The C-terminal
CC       domain recognizes the anticodon region of the tRNA while the acceptor
CC       arm is sandwiched between the N-terminal domains and the catalytic
CC       domain (PubMed:10319817). The N-terminal also contributes to the
CC       precise recognition of tRNA(Thr) (PubMed:10319817). The editing domain
CC       encompasses approximately residues 62-224; when it is removed the
CC       protein mischarges tRNA(Thr) with L-serine (PubMed:15079065,
CC       PubMed:11136973). {ECO:0000269|PubMed:11136973,
CC       ECO:0000269|PubMed:15525511, ECO:0000305|PubMed:10319817,
CC       ECO:0000305|PubMed:15079065}.
CC   -!- DISRUPTION PHENOTYPE: Essential, it cannot be deleted.
CC       {ECO:0000269|PubMed:15507440}.
CC   -!- BIOTECHNOLOGY: A number of inhibitors with high affinity for bacterial
CC       ThrRS and less affinity for human ThrRS have been identified that might
CC       make good antibiotics. {ECO:0000269|PubMed:23362938}.
CC   -!- SIMILARITY: Belongs to the class-II aminoacyl-tRNA synthetase family.
CC       {ECO:0000255|HAMAP-Rule:MF_00184}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; V00291; CAA23560.1; -; Genomic_DNA.
DR   EMBL; U00096; AAC74789.1; -; Genomic_DNA.
DR   EMBL; AP009048; BAA15498.1; -; Genomic_DNA.
DR   EMBL; M13549; AAA24674.1; -; Genomic_DNA.
DR   PIR; G64930; SYECTT.
DR   RefSeq; NP_416234.1; NC_000913.3.
DR   RefSeq; WP_001144202.1; NZ_SSZK01000001.1.
DR   PDB; 1EVK; X-ray; 2.00 A; A/B=242-642.
DR   PDB; 1EVL; X-ray; 1.55 A; A/B/C/D=242-642.
DR   PDB; 1FYF; X-ray; 1.65 A; A/B=242-642.
DR   PDB; 1KOG; X-ray; 3.50 A; A/B/C/D/E/F/G/H=242-642.
DR   PDB; 1QF6; X-ray; 2.90 A; A=1-642.
DR   PDB; 1TJE; X-ray; 1.50 A; A=1-224.
DR   PDB; 1TKE; X-ray; 1.46 A; A=1-224.
DR   PDB; 1TKG; X-ray; 1.50 A; A=1-224.
DR   PDB; 1TKY; X-ray; 1.48 A; A=1-224.
DR   PDB; 4HWO; X-ray; 1.91 A; A/B=242-642.
DR   PDB; 4HWP; X-ray; 1.81 A; A/B=242-642.
DR   PDB; 4HWR; X-ray; 1.90 A; A/B=242-642.
DR   PDB; 4HWS; X-ray; 1.70 A; A/B=242-642.
DR   PDB; 4P3O; X-ray; 2.50 A; A/B=242-642.
DR   PDB; 4P3P; X-ray; 2.10 A; A/B=242-642.
DR   PDBsum; 1EVK; -.
DR   PDBsum; 1EVL; -.
DR   PDBsum; 1FYF; -.
DR   PDBsum; 1KOG; -.
DR   PDBsum; 1QF6; -.
DR   PDBsum; 1TJE; -.
DR   PDBsum; 1TKE; -.
DR   PDBsum; 1TKG; -.
DR   PDBsum; 1TKY; -.
DR   PDBsum; 4HWO; -.
DR   PDBsum; 4HWP; -.
DR   PDBsum; 4HWR; -.
DR   PDBsum; 4HWS; -.
DR   PDBsum; 4P3O; -.
DR   PDBsum; 4P3P; -.
DR   SMR; P0A8M3; -.
DR   BioGRID; 4262193; 27.
DR   BioGRID; 850582; 2.
DR   DIP; DIP-35823N; -.
DR   IntAct; P0A8M3; 50.
DR   MINT; P0A8M3; -.
DR   STRING; 511145.b1719; -.
DR   MoonProt; P0A8M3; -.
DR   iPTMnet; P0A8M3; -.
DR   jPOST; P0A8M3; -.
DR   PaxDb; P0A8M3; -.
DR   PRIDE; P0A8M3; -.
DR   EnsemblBacteria; AAC74789; AAC74789; b1719.
DR   EnsemblBacteria; BAA15498; BAA15498; BAA15498.
DR   GeneID; 58460397; -.
DR   GeneID; 946222; -.
DR   KEGG; ecj:JW1709; -.
DR   KEGG; eco:b1719; -.
DR   PATRIC; fig|1411691.4.peg.538; -.
DR   EchoBASE; EB0994; -.
DR   eggNOG; COG0441; Bacteria.
DR   HOGENOM; CLU_008554_0_1_6; -.
DR   InParanoid; P0A8M3; -.
DR   PhylomeDB; P0A8M3; -.
DR   BioCyc; EcoCyc:THRS-MONOMER; -.
DR   BioCyc; MetaCyc:THRS-MONOMER; -.
DR   BRENDA; 6.1.1.3; 2026.
DR   SABIO-RK; P0A8M3; -.
DR   EvolutionaryTrace; P0A8M3; -.
DR   PRO; PR:P0A8M3; -.
DR   Proteomes; UP000000318; Chromosome.
DR   Proteomes; UP000000625; Chromosome.
DR   GO; GO:0005737; C:cytoplasm; IDA:EcoliWiki.
DR   GO; GO:0005829; C:cytosol; IDA:EcoCyc.
DR   GO; GO:0002161; F:aminoacyl-tRNA editing activity; IDA:EcoCyc.
DR   GO; GO:0004812; F:aminoacyl-tRNA ligase activity; IDA:EcoliWiki.
DR   GO; GO:0005524; F:ATP binding; IDA:EcoliWiki.
DR   GO; GO:0008144; F:drug binding; IDA:EcoliWiki.
DR   GO; GO:0048027; F:mRNA 5'-UTR binding; IDA:EcoCyc.
DR   GO; GO:0003723; F:RNA binding; IDA:EcoliWiki.
DR   GO; GO:0004829; F:threonine-tRNA ligase activity; IDA:EcoCyc.
DR   GO; GO:0000900; F:translation repressor activity, mRNA regulatory element binding; IDA:EcoCyc.
DR   GO; GO:0000049; F:tRNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0008270; F:zinc ion binding; IDA:EcoCyc.
DR   GO; GO:0045947; P:negative regulation of translational initiation; IMP:EcoCyc.
DR   GO; GO:0006417; P:regulation of translation; IDA:EcoCyc.
DR   GO; GO:0046677; P:response to antibiotic; IEA:UniProtKB-KW.
DR   GO; GO:0006435; P:threonyl-tRNA aminoacylation; IDA:EcoCyc.
DR   GO; GO:0043039; P:tRNA aminoacylation; IDA:EcoliWiki.
DR   GO; GO:0006418; P:tRNA aminoacylation for protein translation; IDA:EcoliWiki.
DR   CDD; cd00771; ThrRS_core; 1.
DR   Gene3D; 3.10.20.30; -; 1.
DR   Gene3D; 3.40.50.800; -; 1.
DR   HAMAP; MF_00184; Thr_tRNA_synth; 1.
DR   InterPro; IPR002314; aa-tRNA-synt_IIb.
DR   InterPro; IPR006195; aa-tRNA-synth_II.
DR   InterPro; IPR004154; Anticodon-bd.
DR   InterPro; IPR036621; Anticodon-bd_dom_sf.
DR   InterPro; IPR012675; Beta-grasp_dom_sf.
DR   InterPro; IPR004095; TGS.
DR   InterPro; IPR012676; TGS-like.
DR   InterPro; IPR002320; Thr-tRNA-ligase_IIa.
DR   InterPro; IPR018163; Thr/Ala-tRNA-synth_IIc_edit.
DR   InterPro; IPR033728; ThrRS_core.
DR   InterPro; IPR012947; tRNA_SAD.
DR   PANTHER; PTHR11451; PTHR11451; 1.
DR   Pfam; PF03129; HGTP_anticodon; 1.
DR   Pfam; PF02824; TGS; 1.
DR   Pfam; PF00587; tRNA-synt_2b; 1.
DR   Pfam; PF07973; tRNA_SAD; 1.
DR   PRINTS; PR01047; TRNASYNTHTHR.
DR   SMART; SM00863; tRNA_SAD; 1.
DR   SUPFAM; SSF55186; SSF55186; 1.
DR   SUPFAM; SSF81271; SSF81271; 1.
DR   TIGRFAMs; TIGR00418; thrS; 1.
DR   PROSITE; PS50862; AA_TRNA_LIGASE_II; 1.
DR   PROSITE; PS51880; TGS; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Aminoacyl-tRNA synthetase;
KW   Antibiotic resistance; ATP-binding; Cytoplasm; Ligase; Metal-binding;
KW   Nucleotide-binding; Protein biosynthesis; Reference proteome; Repressor;
KW   RNA-binding; Translation regulation; tRNA-binding; Zinc.
FT   CHAIN           1..642
FT                   /note="Threonine--tRNA ligase"
FT                   /id="PRO_0000100973"
FT   DOMAIN          1..61
FT                   /note="TGS"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01228"
FT   NP_BIND         363..365
FT                   /note="AMP"
FT                   /evidence="ECO:0000269|PubMed:10319817,
FT                   ECO:0007744|PDB:1QF6"
FT   NP_BIND         479..480
FT                   /note="AMP"
FT                   /evidence="ECO:0000269|PubMed:10319817,
FT                   ECO:0007744|PDB:1QF6"
FT   REGION          1..224
FT                   /note="Correctly edits mischarged seryl-tRNA(Thr)"
FT                   /evidence="ECO:0000269|PubMed:15525511"
FT   REGION          1..62
FT                   /note="N1 domain"
FT                   /evidence="ECO:0000305|PubMed:10319817"
FT   REGION          2..241
FT                   /note="N-terminal region which includes the editing domain,
FT                   important for catalytic efficiency, its loss increases
FT                   mischarging with L-serine, deacylation of incorrectly
FT                   charged tRNA no longer occurs, partially complements a
FT                   deletion strain"
FT                   /evidence="ECO:0000269|PubMed:10319817"
FT   REGION          63..224
FT                   /note="N2 domain, the editing domain"
FT                   /evidence="ECO:0000305|PubMed:10319817"
FT   REGION          200..219
FT                   /note="Contacts tRNA acceptor stem"
FT                   /evidence="ECO:0000269|PubMed:10319817"
FT   REGION          243..534
FT                   /note="Catalytic"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_00184,
FT                   ECO:0000305|PubMed:10319817"
FT   REGION          246..249
FT                   /note="Contacts mRNA operator"
FT                   /evidence="ECO:0000269|PubMed:11953757"
FT   REGION          313..317
FT                   /note="Contacts 3'-CCA of tRNA"
FT                   /evidence="ECO:0000269|PubMed:10319817"
FT   REGION          342..349
FT                   /note="Contacts mRNA operator"
FT                   /evidence="ECO:0000269|PubMed:11953757"
FT   REGION          348..349
FT                   /note="Cross-subunit contacts with tRNA(Thr)"
FT                   /evidence="ECO:0000269|PubMed:10319817"
FT   REGION          489..503
FT                   /note="Contacts mRNA operator"
FT                   /evidence="ECO:0000269|PubMed:11953757"
FT   REGION          535..642
FT                   /note="Anticodon recognition"
FT                   /evidence="ECO:0000305|PubMed:10319817"
FT   REGION          547..549
FT                   /note="Contacts anticodon region of tRNA"
FT                   /evidence="ECO:0000269|PubMed:10319817"
FT   REGION          547..549
FT                   /note="Contacts mRNA operator"
FT                   /evidence="ECO:0000269|PubMed:11953757"
FT   REGION          575..586
FT                   /note="Contacts mRNA operator"
FT                   /evidence="ECO:0000269|PubMed:11953757"
FT   REGION          575..583
FT                   /note="Contacts anticodon region of tRNA"
FT                   /evidence="ECO:0000269|PubMed:10319817"
FT   REGION          595..600
FT                   /note="Contacts anticodon region of tRNA"
FT                   /evidence="ECO:0000269|PubMed:10319817"
FT   REGION          595..600
FT                   /note="Contacts mRNA operator"
FT                   /evidence="ECO:0000269|PubMed:11953757"
FT   METAL           334
FT                   /note="Zinc"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_00184,
FT                   ECO:0000269|PubMed:10319817, ECO:0000269|PubMed:10881191,
FT                   ECO:0000269|PubMed:11136973, ECO:0000269|PubMed:11953757"
FT   METAL           385
FT                   /note="Zinc; via tele nitrogen"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_00184,
FT                   ECO:0000269|PubMed:10319817, ECO:0000269|PubMed:10881191,
FT                   ECO:0000269|PubMed:11136973, ECO:0000269|PubMed:11953757"
FT   METAL           511
FT                   /note="Zinc; via pros nitrogen"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_00184,
FT                   ECO:0000269|PubMed:10319817, ECO:0000269|PubMed:10881191,
FT                   ECO:0000269|PubMed:11136973"
FT   BINDING         309
FT                   /note="Binds 2'-OH of adenine 76 of tRNA(Thr), the tRNA
FT                   acceptor base"
FT                   /evidence="ECO:0000269|PubMed:10319817,
FT                   ECO:0007744|PDB:1QF6"
FT   BINDING         325
FT                   /note="Cross-subunit contacts with tRNA(Thr)"
FT                   /evidence="ECO:0000269|PubMed:10319817"
FT   BINDING         363
FT                   /note="Contacts 3'-CCA of tRNA"
FT                   /evidence="ECO:0000269|PubMed:10319817"
FT   BINDING         375
FT                   /note="Contacts 3'-CCA of tRNA"
FT                   /evidence="ECO:0000269|PubMed:10319817"
FT   BINDING         376
FT                   /note="AMP; via amide nitrogen and carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:10319817,
FT                   ECO:0007744|PDB:1QF6"
FT   BINDING         379
FT                   /note="AMP"
FT                   /evidence="ECO:0000269|PubMed:10319817"
FT   BINDING         381
FT                   /note="AMP"
FT                   /evidence="ECO:0000269|PubMed:10319817,
FT                   ECO:0007744|PDB:1QF6"
FT   BINDING         462
FT                   /note="Contacts 3'-CCA of tRNA"
FT                   /evidence="ECO:0000269|PubMed:10319817"
FT   BINDING         484
FT                   /note="Contacts 3'-CCA of tRNA"
FT                   /evidence="ECO:0000269|PubMed:10319817"
FT   BINDING         517
FT                   /note="AMP"
FT                   /evidence="ECO:0000269|PubMed:10319817,
FT                   ECO:0007744|PDB:1QF6"
FT   BINDING         520
FT                   /note="AMP"
FT                   /evidence="ECO:0000269|PubMed:10319817"
FT   BINDING         589
FT                   /note="Contacts anticodon region of tRNA"
FT                   /evidence="ECO:0000269|PubMed:10319817"
FT   BINDING         609
FT                   /note="Contacts anticodon region of tRNA"
FT                   /evidence="ECO:0000269|PubMed:10319817"
FT   BINDING         609
FT                   /note="Contacts mRNA operator"
FT                   /evidence="ECO:0000269|PubMed:11953757"
FT   BINDING         615
FT                   /note="Contacts mRNA operator"
FT                   /evidence="ECO:0000269|PubMed:11953757"
FT   MOD_RES         286
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_00184,
FT                   ECO:0000269|PubMed:18723842"
FT   MUTAGEN         73..77
FT                   /note="HSCAH->ASCAA: No longer edits mischarged L-seryl-
FT                   tRNA(Thr), mischarges tRNA(Thr) with L-serine, correct
FT                   acylation is unaffected."
FT                   /evidence="ECO:0000269|PubMed:11136973"
FT   MUTAGEN         156
FT                   /note="K->A: Mischarges tRNA(Thr) with L-serine."
FT                   /evidence="ECO:0000269|PubMed:15525511"
FT   MUTAGEN         180
FT                   /note="D->A: No longer edits mischarged L-seryl-tRNA(Thr),
FT                   mischarges tRNA(Thr) with L-serine, correct acylation is
FT                   unaffected."
FT                   /evidence="ECO:0000269|PubMed:11136973"
FT   MUTAGEN         182
FT                   /note="C->A: Very high mischarging of tRNA(Thr) with L-
FT                   serine."
FT                   /evidence="ECO:0000269|PubMed:15525511"
FT   MUTAGEN         186
FT                   /note="H->A: Mischarges tRNA(Thr) with L-serine."
FT                   /evidence="ECO:0000269|PubMed:15525511"
FT   MUTAGEN         296
FT                   /note="P->S: Confers resistance to borrelidin (BN); KM for
FT                   L-Thr is unchanged, KM for ATP increases to 187 uM, KI for
FT                   BN increases to 4.5 nM."
FT                   /evidence="ECO:0000269|PubMed:15507440"
FT   MUTAGEN         307
FT                   /note="T->A: KI for BN increases 10-fold, no change in
FT                   aminoacylation activity."
FT                   /evidence="ECO:0000269|PubMed:15507440"
FT   MUTAGEN         309
FT                   /note="H->A: 10-fold increase in KM for Thr for activation,
FT                   240-fold decrease in aminoacyl transfer. Cells have a long
FT                   lag phase and reach stationary phase at a lower cell
FT                   density. KI for BN increases 1000-fold, supports growth in
FT                   the presence of BN."
FT                   /evidence="ECO:0000269|PubMed:15507440,
FT                   ECO:0000269|PubMed:18997014"
FT   MUTAGEN         334
FT                   /note="C->S: Does not complement a deletion strain."
FT                   /evidence="ECO:0000269|PubMed:10319817"
FT   MUTAGEN         337
FT                   /note="H->A: KI for BN increases 12-fold, no change in
FT                   aminoacylation activity, supports growth in the presence of
FT                   BN."
FT                   /evidence="ECO:0000269|PubMed:15507440"
FT   MUTAGEN         363
FT                   /note="R->A: 700-fold decrease in kcat for Thr activation,
FT                   1000-fold decrease in kcat of aminoacylation, no change in
FT                   KM."
FT                   /evidence="ECO:0000269|PubMed:18997014"
FT   MUTAGEN         381
FT                   /note="Q->A: 100-fold increase in KM for Thr for
FT                   activation."
FT                   /evidence="ECO:0000269|PubMed:18997014"
FT   MUTAGEN         385
FT                   /note="H->A,N: Does not complement a deletion strain."
FT                   /evidence="ECO:0000269|PubMed:10319817"
FT   MUTAGEN         465
FT                   /note="K->A: 35-fold decrease in kcat for Thr activation,
FT                   570-fold decrease in kcat of aminoacylation, no change in
FT                   KM."
FT                   /evidence="ECO:0000269|PubMed:18997014"
FT   MUTAGEN         479
FT                   /note="Q->A: Wild-type Thr activation and aminoacylation."
FT                   /evidence="ECO:0000269|PubMed:18997014"
FT   MUTAGEN         489
FT                   /note="L->M: Confers resistance to borrelidin (BN); KM for
FT                   L-thr is unchanged, KM for ATP increases to 163 uM, KI for
FT                   BN increases to 7.8 nM, supports growth in the presence of
FT                   BN."
FT                   /evidence="ECO:0000269|PubMed:15507440"
FT   MUTAGEN         489
FT                   /note="L->W: KI for BN increases 1500-fold, no change in
FT                   aminoacylation activity, supports growth in the presence of
FT                   BN."
FT                   /evidence="ECO:0000269|PubMed:15507440"
FT   MUTAGEN         511
FT                   /note="H->A,N: Does not complement a deletion strain, has
FT                   dominant lethal effect in presence of wild-type gene,
FT                   probably due to repression of the wild-type gene."
FT                   /evidence="ECO:0000269|PubMed:10319817"
FT   MUTAGEN         531
FT                   /note="G->GEGK: KI for BN increases 8-fold, decreases
FT                   aminoacylation activity, does not support growth in the
FT                   presence of BN."
FT                   /evidence="ECO:0000269|PubMed:15507440"
FT   CONFLICT        195
FT                   /note="H -> R (in Ref. 1; CAA23560)"
FT                   /evidence="ECO:0000305"
FT   STRAND          3..5
FT                   /evidence="ECO:0007744|PDB:1TKE"
FT   STRAND          11..13
FT                   /evidence="ECO:0007744|PDB:1TKE"
FT   HELIX           20..27
FT                   /evidence="ECO:0007744|PDB:1TKE"
FT   HELIX           29..34
FT                   /evidence="ECO:0007744|PDB:1TKE"
FT   STRAND          37..40
FT                   /evidence="ECO:0007744|PDB:1TKE"
FT   STRAND          43..46
FT                   /evidence="ECO:0007744|PDB:1TKE"
FT   STRAND          55..60
FT                   /evidence="ECO:0007744|PDB:1TKE"
FT   HELIX           65..86
FT                   /evidence="ECO:0007744|PDB:1TKE"
FT   STRAND          101..107
FT                   /evidence="ECO:0007744|PDB:1TKE"
FT   HELIX           114..128
FT                   /evidence="ECO:0007744|PDB:1TKE"
FT   STRAND          135..138
FT                   /evidence="ECO:0007744|PDB:1TKE"
FT   HELIX           141..150
FT                   /evidence="ECO:0007744|PDB:1TKE"
FT   HELIX           154..163
FT                   /evidence="ECO:0007744|PDB:1TKE"
FT   STRAND          171..175
FT                   /evidence="ECO:0007744|PDB:1TKE"
FT   STRAND          178..183
FT                   /evidence="ECO:0007744|PDB:1TKE"
FT   HELIX           190..192
FT                   /evidence="ECO:0007744|PDB:1TKE"
FT   STRAND          196..205
FT                   /evidence="ECO:0007744|PDB:1TKE"
FT   HELIX           206..208
FT                   /evidence="ECO:0007744|PDB:1TKE"
FT   STRAND          214..222
FT                   /evidence="ECO:0007744|PDB:1TKE"
FT   HELIX           226..240
FT                   /evidence="ECO:0007744|PDB:1QF6"
FT   HELIX           244..250
FT                   /evidence="ECO:0007744|PDB:1EVL"
FT   HELIX           268..287
FT                   /evidence="ECO:0007744|PDB:1EVL"
FT   STRAND          297..300
FT                   /evidence="ECO:0007744|PDB:1EVL"
FT   HELIX           301..306
FT                   /evidence="ECO:0007744|PDB:1EVL"
FT   HELIX           309..312
FT                   /evidence="ECO:0007744|PDB:1EVL"
FT   HELIX           314..316
FT                   /evidence="ECO:0007744|PDB:1EVL"
FT   STRAND          319..322
FT                   /evidence="ECO:0007744|PDB:1EVL"
FT   STRAND          325..329
FT                   /evidence="ECO:0007744|PDB:1EVL"
FT   STRAND          331..333
FT                   /evidence="ECO:0007744|PDB:1QF6"
FT   HELIX           334..341
FT                   /evidence="ECO:0007744|PDB:1EVL"
FT   HELIX           348..350
FT                   /evidence="ECO:0007744|PDB:1EVL"
FT   STRAND          352..362
FT                   /evidence="ECO:0007744|PDB:1EVL"
FT   HELIX           367..369
FT                   /evidence="ECO:0007744|PDB:1EVL"
FT   TURN            372..374
FT                   /evidence="ECO:0007744|PDB:1EVL"
FT   STRAND          377..388
FT                   /evidence="ECO:0007744|PDB:1EVL"
FT   HELIX           390..392
FT                   /evidence="ECO:0007744|PDB:1EVL"
FT   HELIX           393..409
FT                   /evidence="ECO:0007744|PDB:1EVL"
FT   TURN            410..412
FT                   /evidence="ECO:0007744|PDB:1EVL"
FT   STRAND          417..421
FT                   /evidence="ECO:0007744|PDB:1EVL"
FT   HELIX           431..447
FT                   /evidence="ECO:0007744|PDB:1EVL"
FT   STRAND          453..455
FT                   /evidence="ECO:0007744|PDB:1EVL"
FT   STRAND          461..463
FT                   /evidence="ECO:0007744|PDB:4HWR"
FT   STRAND          465..471
FT                   /evidence="ECO:0007744|PDB:1EVL"
FT   STRAND          477..488
FT                   /evidence="ECO:0007744|PDB:1EVL"
FT   HELIX           489..492
FT                   /evidence="ECO:0007744|PDB:1EVL"
FT   STRAND          502..505
FT                   /evidence="ECO:0007744|PDB:1EVK"
FT   STRAND          508..517
FT                   /evidence="ECO:0007744|PDB:1EVL"
FT   HELIX           518..529
FT                   /evidence="ECO:0007744|PDB:1EVL"
FT   TURN            535..537
FT                   /evidence="ECO:0007744|PDB:1EVL"
FT   STRAND          542..548
FT                   /evidence="ECO:0007744|PDB:1EVL"
FT   HELIX           549..551
FT                   /evidence="ECO:0007744|PDB:1EVL"
FT   HELIX           552..564
FT                   /evidence="ECO:0007744|PDB:1EVL"
FT   STRAND          569..572
FT                   /evidence="ECO:0007744|PDB:1EVL"
FT   STRAND          574..576
FT                   /evidence="ECO:0007744|PDB:4P3O"
FT   HELIX           578..587
FT                   /evidence="ECO:0007744|PDB:1EVL"
FT   STRAND          591..596
FT                   /evidence="ECO:0007744|PDB:1EVL"
FT   HELIX           598..603
FT                   /evidence="ECO:0007744|PDB:1EVL"
FT   STRAND          605..610
FT                   /evidence="ECO:0007744|PDB:1EVL"
FT   STRAND          615..620
FT                   /evidence="ECO:0007744|PDB:1EVL"
FT   HELIX           621..633
FT                   /evidence="ECO:0007744|PDB:1EVL"
SQ   SEQUENCE   642 AA;  74014 MW;  38D8913B19CDAB7B CRC64;
     MPVITLPDGS QRHYDHAVSP MDVALDIGPG LAKACIAGRV NGELVDACDL IENDAQLSII
     TAKDEEGLEI IRHSCAHLLG HAIKQLWPHT KMAIGPVIDN GFYYDVDLDR TLTQEDVEAL
     EKRMHELAEK NYDVIKKKVS WHEARETFAN RGESYKVSIL DENIAHDDKP GLYFHEEYVD
     MCRGPHVPNM RFCHHFKLMK TAGAYWRGDS NNKMLQRIYG TAWADKKALN AYLQRLEEAA
     KRDHRKIGKQ LDLYHMQEEA PGMVFWHNDG WTIFRELEVF VRSKLKEYQY QEVKGPFMMD
     RVLWEKTGHW DNYKDAMFTT SSENREYCIK PMNCPGHVQI FNQGLKSYRD LPLRMAEFGS
     CHRNEPSGSL HGLMRVRGFT QDDAHIFCTE EQIRDEVNGC IRLVYDMYST FGFEKIVVKL
     STRPEKRIGS DEMWDRAEAD LAVALEENNI PFEYQLGEGA FYGPKIEFTL YDCLDRAWQC
     GTVQLDFSLP SRLSASYVGE DNERKVPVMI HRAILGSMER FIGILTEEFA GFFPTWLAPV
     QVVIMNITDS QSEYVNELTQ KLSNAGIRVK ADLRNEKIGF KIREHTLRRV PYMLVCGDKE
     VESGKVAVRT RRGKDLGSMD VNEVIEKLQQ EIRSRSLKQL EE
//
